Sara Bonstein

Insider Reports History

Location
305 College Road East, Princeton, NJ
Signature
/s/ John H. Tucker, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sara Bonstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INSMED Inc Chief Financial Officer Common Stock 113K $8.1M $71.50 Jun 3, 2025 Direct
INSMED Inc Chief Financial Officer Stock Option (right to buy) 0 $654K $20.49 Jul 21, 2025 Direct
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 31K Jun 11, 2025 Direct
scPharmaceuticals Inc. Director Stock Option (Right to Buy) 0 Oct 7, 2025 Direct

Insider Reports Filed by Sara Bonstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SCPH scPharmaceuticals Inc. Oct 7, 2025 3 $0 4 Oct 7, 2025 Director
INSM INSMED Inc Jul 21, 2025 10 -$4.53M 4 Jul 23, 2025 Chief Financial Officer
INSM INSMED Inc Jul 7, 2025 10 -$4.32M 4 Jul 9, 2025 Chief Financial Officer
INSM INSMED Inc Jun 23, 2025 6 -$4.96M 4 Jun 25, 2025 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 12, 2025 Director
INSM INSMED Inc Jun 10, 2025 10 -$4.29M 4 Jun 12, 2025 Chief Financial Officer
SCPH scPharmaceuticals Inc. Jun 3, 2025 1 $0 4 Jun 5, 2025 Director
INSM INSMED Inc Jun 3, 2025 1 -$113K 4 Jun 4, 2025 Chief Financial Officer
INSM INSMED Inc May 15, 2025 2 $0 4 May 19, 2025 Chief Financial Officer
INSM INSMED Inc May 13, 2025 2 -$709K 4 May 15, 2025 Chief Financial Officer
INSM INSMED Inc Feb 18, 2025 2 -$1.47M 4 Feb 20, 2025 Chief Financial Officer
INSM INSMED Inc Feb 11, 2025 2 -$1.47M 4 Feb 13, 2025 Chief Financial Officer
INSM INSMED Inc Feb 5, 2025 2 -$2.3M 4 Feb 7, 2025 Chief Financial Officer
INSM INSMED Inc Jan 7, 2025 5 -$393K 4 Jan 10, 2025 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
SCPH scPharmaceuticals Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
INSM INSMED Inc May 28, 2024 26 -$5.66M 4 May 30, 2024 Chief Financial Officer
INSM INSMED Inc May 13, 2024 3 -$281K 4 May 15, 2024 Chief Financial Officer
INSM INSMED Inc Jan 9, 2024 1 -$131K 4 Jan 11, 2024 Chief Financial Officer
INSM INSMED Inc Jan 4, 2024 2 $0 4 Jan 5, 2024 Chief Financial Officer
INSM INSMED Inc Dec 22, 2023 1 -$396K 4 Dec 22, 2023 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
SCPH scPharmaceuticals Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
INSM INSMED Inc May 15, 2023 2 -$72.4K 4 May 17, 2023 Chief Financial Officer
INSM INSMED Inc May 11, 2023 3 $0 4 May 15, 2023 Chief Financial Officer
INSM INSMED Inc Jan 10, 2023 1 -$51.8K 4 Jan 12, 2023 Chief Financial Officer
INSM INSMED Inc Jan 5, 2023 3 $0 4 Jan 6, 2023 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
SCPH scPharmaceuticals Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
INSM INSMED Inc May 16, 2022 1 -$26.5K 4 May 18, 2022 Chief Financial Officer
INSM INSMED Inc May 11, 2022 2 $0 4 May 13, 2022 Chief Financial Officer
INSM INSMED Inc Jan 11, 2022 1 -$29K 4 Jan 13, 2022 Chief Financial Officer
INSM INSMED Inc Jan 6, 2022 2 $0 4 Jan 10, 2022 Chief Financial Officer
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Director
SCPH scPharmaceuticals Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
INSM INSMED Inc May 12, 2021 2 $0 4 May 14, 2021 Chief Financial Officer